Advances in treatment of chronic myelogenous leukemia

Clinical Focus ›› 2014, Vol. 29 ›› Issue (10): 1126-1.12911e+007.

LI Zhen;FANG Bai-jun

CLC Number:

LI Zhen;FANG Bai-jun. Advances in treatment of chronic myelogenous leukemia[J]. Clinical Focus, 2014, 29(10): 1126-1.12911e+007.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

[1]	Wang Hui, Chen Man. Flow cytometry in minimal residual disease detection of acute myeloid leukemia: current status and progress [J]. Clinical Focus, 2021, 36(10): 889-895.
[2]	Lu Wenyi, Zhao Mingfeng. The standard treatment of acute lymphoblastic leukemia [J]. Clinical Focus, 2021, 36(10): 874-879.
[3]	Ren Jinhai， Guo Xiaonan. Clinical advances on neoplastic haematologic disorders in 2017 [J]. Clinical Focus, 2018, 33(1): 40-45.
[4]	Chen Yongquan， Yang Ting. Current treatment strategies for refractory/relapsed Hodgkin's lymphoma [J]. Clinical Focus, 2017, 32(12): 1022-1026.
[5]	Ren Jinhai;Guo Xiaonan;Lin Fengru. Advance in acute myeloid leukemia therapy 2014 [J]. Clinical Focus, 2015, 30(2): 157-160.
[6]	REN Jin-hai;GUO Xiao-nan;LIN Feng-ru. Update on chronic myelogenous leukemia and other chronic myeloproliferative neoplasms in 2013 [J]. CLINICAL FOCUS, 2014, 29(3): 270-274.
[7]	CUI Jiu-wei. Treatments of chronic lymphocytic leukemia [J]. Clinical Focus, 2014, 29(10): 1119-1125.
[8]	GUO Xiao-ling. Updates in treatment of relapsed and refractory acute myeloid leukemia [J]. Clinical Focus, 2014, 29(10): 1108-1113.
[9]	WEI Hui. Treatment of acute lymphoblastic leukemia [J]. Clinical Focus, 2014, 29(10): 1100-1103.

PDF (PC)